In-Jin Jang (In Jin Jang)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 48

Top Topics

Gas Chromatography

Top Venues

Drug design, development and therapy

Clinical and translational science

Translational and clinical pharmacology

Investigational new drugs

This page only lists publications with an associated author ORCID identifier.

Publications

Ki Young Huh, Sejung Hwang, Joo Young Na, Kyung-Sang Yu, In-Jin Jang, Jae-Young Chung, Seonghae Yoon
Estimation of the benefit from pre-emptive genotyping based on the nationwide cohort data in South Korea. Clinical and translational science 17 (3) (2024)
Ki Young Huh, Sejung Hwang, Joo Young Na, Kyung-Sang Yu, In-Jin Jang, Jae-Young Chung, Seonghae Yoon
Estimation of the benefit from pre-emptive genotyping based on the nationwide cohort data in South Korea. Clinical and translational science 17 (3) (2024)
Heejae Won, Eunwoo Kim, Jihye Chae, Hyejung Lee, Joo-Youn Cho, In-Jin Jang, Jae-Young Chung, Min Gul Kim, Seung Hwan Lee
Pharmacokinetic interactions between fexuprazan, a potassium-competitive acid blocker, and nonsteroidal anti-inflammatory drugs in healthy males. Clinical and translational science 17 (5) (2024)
Ki Young Huh, Sejung Hwang, Joo Young Na, Kyung-Sang Yu, In-Jin Jang, Jae-Young Chung, Seonghae Yoon
Estimation of the benefit from pre-emptive genotyping based on the nationwide cohort data in South Korea. Clinical and translational science 17 (3) (2024)
Juyoung Khwarg, Soyoung Lee, In-Jin Jang, Won-Ho Kang, Hye Jung Lee, Kyu Yeon Kim, Ki-Sun Jeong, Chongho Won, Youn Woong Choi, Dae Chul Ha, RaeHoon Jung, Min-Gu Han, Won Tae Jung, Kyu-Yeol Nam, YeSeul Kim, Kyung-Sang Yu, Jaeseong Oh
Pharmacokinetic Comparison Between a Fixed-Dose Combination of Atorvastatin/Omega-3-Acid Ethyl Esters and the Corresponding Loose Combination in Healthy Korean Male Subjects. Drug design, development and therapy 18 (2024)
Hyunwook Ryu, Hyun Chul Kim, Inseung Jeon, In-Jin Jang, Joo-Youn Cho, Kyung Tae Kim, Jaeseong Oh
Pharmacokinetic Interactions Between the Fixed-Dose Combination of Ezetimibe/Rosuvastatin 10/20 Mg and the Fixed-Dose Combination of Telmisartan/Amlodipine 80/5 Mg in Healthy Subjects. Drug design, development and therapy 18 (2024)
Ki Young Huh, Sejung Hwang, Joo Young Na, Kyung-Sang Yu, In-Jin Jang, Jae-Young Chung, Seonghae Yoon
Estimation of the benefit from pre-emptive genotyping based on the nationwide cohort data in South Korea. Clinical and translational science 17 (3) (2024)
Juyoung Khwarg, Soyoung Lee, In-Jin Jang, Won-Ho Kang, Hye Jung Lee, Kyu Yeon Kim, Ki-Sun Jeong, Chongho Won, Youn Woong Choi, Dae Chul Ha, RaeHoon Jung, Min-Gu Han, Won Tae Jung, Kyu-Yeol Nam, YeSeul Kim, Kyung-Sang Yu, Jaeseong Oh
Pharmacokinetic Comparison Between a Fixed-Dose Combination of Atorvastatin/Omega-3-Acid Ethyl Esters and the Corresponding Loose Combination in Healthy Korean Male Subjects. Drug design, development and therapy 18 (2024)
Heejae Won, Eunwoo Kim, Jihye Chae, Hyejung Lee, Joo-Youn Cho, In-Jin Jang, Jae-Young Chung, Min Gul Kim, Seung Hwan Lee
Pharmacokinetic interactions between fexuprazan, a potassium-competitive acid blocker, and nonsteroidal anti-inflammatory drugs in healthy males. Clinical and translational science 17 (5) (2024)
Heejae Won, Eunwoo Kim, Jihye Chae, Hyejung Lee, Joo-Youn Cho, In-Jin Jang, Jae-Young Chung, Min Gul Kim, Seung Hwan Lee
Pharmacokinetic interactions between fexuprazan, a potassium-competitive acid blocker, and nonsteroidal anti-inflammatory drugs in healthy males. Clinical and translational science 17 (5) (2024)
Hyunwook Ryu, Hyun Chul Kim, Inseung Jeon, In-Jin Jang, Joo-Youn Cho, Kyung Tae Kim, Jaeseong Oh
Pharmacokinetic Interactions Between the Fixed-Dose Combination of Ezetimibe/Rosuvastatin 10/20 Mg and the Fixed-Dose Combination of Telmisartan/Amlodipine 80/5 Mg in Healthy Subjects. Drug design, development and therapy 18 (2024)
Hyun Chul Kim, Eunsol Yang, Soyoung Lee, Jaeseong Oh, Myongjae Lee, ChaeEun Lee, Kyoung Soo Ha, Won Sik Choy, In-Jin Jang, Kyung-Sang Yu
Effects of food and ethnicity on the pharmacokinetics of venadaparib, a next-generation PARP inhibitor, in healthy Korean, Caucasian, and Chinese male subjects. Investigational new drugs 42 (1) (2023)
Hyun Chul Kim, Sangmi Lee, Siyoung Sung, Eunjin Kim, In-Jin Jang, Jae-Young Chung
A Comparison of the Pharmacokinetics and Safety of Dapagliflozin Formate, an Ester Prodrug of Dapagliflozin, to Dapagliflozin Propanediol Monohydrate in Healthy Subjects. Drug design, development and therapy 17 (2023)
Hyun Chul Kim, Eunsol Yang, Soyoung Lee, Jaeseong Oh, Myongjae Lee, ChaeEun Lee, Kyoung Soo Ha, Won Sik Choy, In-Jin Jang, Kyung-Sang Yu
Effects of food and ethnicity on the pharmacokinetics of venadaparib, a next-generation PARP inhibitor, in healthy Korean, Caucasian, and Chinese male subjects. Investigational new drugs 42 (1) (2023)
Hyun Chul Kim, Sangmi Lee, Siyoung Sung, Eunjin Kim, In-Jin Jang, Jae-Young Chung
A Comparison of the Pharmacokinetics and Safety of Dapagliflozin Formate, an Ester Prodrug of Dapagliflozin, to Dapagliflozin Propanediol Monohydrate in Healthy Subjects. Drug design, development and therapy 17 (2023)
Hyun Chul Kim, Eunsol Yang, Soyoung Lee, Jaeseong Oh, Myongjae Lee, ChaeEun Lee, Kyoung Soo Ha, Won Sik Choy, In-Jin Jang, Kyung-Sang Yu
Effects of food and ethnicity on the pharmacokinetics of venadaparib, a next-generation PARP inhibitor, in healthy Korean, Caucasian, and Chinese male subjects. Investigational new drugs (2023)
Hyun Chul Kim, Eunsol Yang, Soyoung Lee, Jaeseong Oh, Myongjae Lee, ChaeEun Lee, Kyoung Soo Ha, Won Sik Choy, In-Jin Jang, Kyung-Sang Yu
Effects of food and ethnicity on the pharmacokinetics of venadaparib, a next-generation PARP inhibitor, in healthy Korean, Caucasian, and Chinese male subjects. Investigational new drugs 42 (1) (2023)
Hyun Chul Kim, Eunsol Yang, Mu Seong Ban, Yu-Kyong Kim, Sung Hee Hong, Jin-A Jung, In-Jin Jang, Seung Hwan Lee
Pharmacokinetics and Pharmacodynamics of Esomezol DR, a New Dual Delayed-Release Formulation of Esomeprazole 20 Mg or 40 Mg, in Healthy Subjects. Drug design, development and therapy 17 (2023)
Hyunjoon Lee, Sejung Hwang, In-Jin Jang, Jae-Young Chung, Jaeseong Oh
Adaptive design clinical trials: current status by disease and trial phase in various perspectives. Translational and clinical pharmacology 31 (4) (2023)
Seolah Lee, Hyun Chul Kim, Yoonhyuk Jang, Han Sang Lee, Seon-Jae Ahn, Soon Tae Lee, Keun Hwa Jung, Kyung-Il Park, Ki-Young Jung, Jaeseong Oh, Seung Hwan Lee, Kyung-Sang Yu, In-Jin Jang, Soyoung Lee, Kon Chu, Sang Kun Lee
Topiramate dosage optimization for effective antiseizure management via population pharmacokinetic modeling. Annals of clinical and translational neurology (2023)
Hyunjoon Lee, Sejung Hwang, In-Jin Jang, Jae-Young Chung, Jaeseong Oh
Adaptive design clinical trials: current status by disease and trial phase in various perspectives. Translational and clinical pharmacology 31 (4) (2023)
Hyun Chul Kim, Eunsol Yang, Soyoung Lee, Jaeseong Oh, Myongjae Lee, ChaeEun Lee, Kyoung Soo Ha, Won Sik Choy, In-Jin Jang, Kyung-Sang Yu
Effects of food and ethnicity on the pharmacokinetics of venadaparib, a next-generation PARP inhibitor, in healthy Korean, Caucasian, and Chinese male subjects. Investigational new drugs 42 (1) (2023)
Hyun Chul Kim, Sangmi Lee, Siyoung Sung, Eunjin Kim, In-Jin Jang, Jae-Young Chung
A Comparison of the Pharmacokinetics and Safety of Dapagliflozin Formate, an Ester Prodrug of Dapagliflozin, to Dapagliflozin Propanediol Monohydrate in Healthy Subjects. Drug design, development and therapy 17 (2023)
Hyun Chul Kim, Eunsol Yang, Soyoung Lee, Jaeseong Oh, Myongjae Lee, ChaeEun Lee, Kyoung Soo Ha, Won Sik Choy, In-Jin Jang, Kyung-Sang Yu
Effects of food and ethnicity on the pharmacokinetics of venadaparib, a next-generation PARP inhibitor, in healthy Korean, Caucasian, and Chinese male subjects. Investigational new drugs 42 (1) (2023)
Hyun Chul Kim, Sangmi Lee, Siyoung Sung, Eunjin Kim, In-Jin Jang, Jae-Young Chung
A Comparison of the Pharmacokinetics and Safety of Dapagliflozin Formate, an Ester Prodrug of Dapagliflozin, to Dapagliflozin Propanediol Monohydrate in Healthy Subjects. Drug design, development and therapy 17 (2023)
Sae Im Jeong, Yun Kim, Jae Jin Nah, Wan Huh, In-Jin Jang, Jun Gi Hwang, Seung Hwan Lee
Pharmacokinetic and pharmacodynamic interaction of DWP16001, a sodium-glucose cotransporter 2 inhibitor, with gemigliptin and metformin in healthy adults. British journal of clinical pharmacology (2022)
Sae Im Jeong, Yun Kim, Jae Jin Nah, Wan Huh, In-Jin Jang, Jun Gi Hwang, Seung Hwan Lee
Pharmacokinetic and Pharmacodynamic Interaction of DWP16001, an SGLT2 Inhibitor, with Gemigliptin and Metformin in Healthy Adults. British journal of clinical pharmacology (2022)
Jun Gi Hwang, Seung Hwan Lee, Wan Huh, Jumi Han, Jaeseong Oh, In-Jin Jang, Kyung-Sang Yu
Dose-dependent glucosuria of DWP16001, a novel selective sodium-glucose cotransporter-2 inhibitor, in healthy subjects. British journal of clinical pharmacology 88 (9) (2022)
Hyun Chul Kim, Deok Yong Yoon, Seung Hwan Lee, In-Jin Jang, Jang-Hee Hong, Jae Woo Kim
Comparative pharmacokinetics between two tablets of tramadol 37.5 mg/acetaminophen 325 mg and one tablet of tramadol 75 mg/acetaminophen 650 mg for extended-release fixed-dose combination. Translational and clinical pharmacology 30 (2) (2022)
Eunsol Yang, Hyounggyoon Yoo, In-Jin Jang, Kyung-Sang Yu, Seung Hwan Lee
Pharmacokinetic and Pharmacodynamic Comparison of Two Formulations of a Fixed-Dose Combination of Gemigliptin/Rosuvastatin 50/20 mg: A Randomized, Open-Label, Single-Dose, Two-Way Crossover Study. Drug design, development and therapy 15 (2021)
Inseung Jeon, Jaeseong Oh, Yu-Kyung Kwon, Seo Hyun Yoon, Joo-Youn Cho, In-Jin Jang, Kyung-Sang Yu, Seung Hwan Lee
Comparison of Pharmacokinetic, Pharmacodynamic and Tolerability Profiles of CKD-11101, Darbepoetin Alfa (NESP®) Biosimilar, to Those of NESP® After a Single Subcutaneous or Intravenous Administration to Healthy Subjects. Drug design, development and therapy 15 (2021)
Sungyeun Bae, Jihoon Kwon, Si-Beum Lee, In-Jin Jang, Kyung-Sang Yu, Seung Hwan Lee
Comparative Pharmacokinetics/Pharmacodynamics of Fixed-Dose Combination of Esomeprazole and Calcium Carbonate (AD-206) to the Conventional Esomeprazole. Drug design, development and therapy 15 (2021)
Jihyun Jung, Soyoung Lee, Jaeseong Oh, Seung Hwan Lee, In-Jin Jang, Donghwan Lee, Kyung-Sang Yu
Pharmacokinetic comparison between a fixed-dose combination of fimasartan/amlodipine/hydrochlorothiazide 60/10/25 mg and a corresponding loose combination of fimasartan/amlodipine 60/25 mg and hydrochlorothiazide 25 mg in healthy subjects. Translational and clinical pharmacology 29 (1) (2021)
Inseung Jeon, Yu-Kyong Kim, Ildae Song, Deok Yong Yoon, Ki Young Huh, Xuanyou Jin, Kyung-Sang Yu, Seung Hwan Lee, Yuji Kumagai, In-Jin Jang
The necessary conduct: Exploratory multiregional clinical trials in East Asia. Clinical and translational science 14 (6) (2021)
Jihyun Kang, Andrew HyoungJin Kim, Inseung Jeon, Jaeseong Oh, In-Jin Jang, Seung Hwan Lee, Joo-Youn Cho
Endogenous metabolic markers for predicting the activity of dihydropyrimidine dehydrogenase. Clinical and translational science (2021)
Sejung Hwang, Dae Young Lee, Joo-Youn Cho, Jae-Yong Chung, In-Jin Jang, Kyung-Sang Yu, Seung Hwan Lee
Pharmacokinetics, Tolerability and Pharmacogenetics of DA-8031 After Multiple Ascending Doses in Healthy Male Subjects. Drug design, development and therapy 15 (2021)
Byungwook Kim, Deok Yong Yoon, Seung Hwan Lee, In-Jin Jang, Kyung-Sang Yu, Joo-Youn Cho, Jaeseong Oh
Comprehensive analysis of important pharmacogenes in Koreans using the DMET™ platform. Translational and clinical pharmacology 29 (3) (2021)
Inyoung Hwang, Yun Kim, Hyounggyoon Yoo, In-Jin Jang, Kyung-Sang Yu, Seung Hwan Lee
Pharmacokinetic/Pharmacodynamic Interaction Between Evogliptin and Pioglitazone in Healthy Male Subjects. Drug design, development and therapy 14 (2020)
Hyounggyoon Yoo, Yun Kim, In-Jin Jang, Kyung-Sang Yu, Seung Hwan Lee
Pharmacokinetic/Pharmacodynamic Interactions Between Evogliptin and Glimepiride in Healthy Male Subjects. Drug design, development and therapy 14 (2020)
Deok Yong Yoon, Soyoung Lee, Mu Seong Ban, In-Jin Jang, Seung Hwan Lee
Pharmacogenomic information from CPIC and DPWG guidelines and its application on drug labels. Translational and clinical pharmacology 28 (4) (2020)
Deok Yong Yoon, Sang In Park, Jin-A Jung, Yong-Il Kim, In-Jin Jang, Jae-Young Chung
Comparison of Pharmacokinetics of a Fixed-Dose Combination of Amlodipine/Losartan/Rosuvastatin with Concomitant Administration of Amlodipine/Losartan and Rosuvastatin in Healthy Volunteers. Drug design, development and therapy 14 (2020)
Jung Sunwoo, Sang Chun Ji, Jaeseong Oh, Mu Seong Ban, Ji Yeon Nam, Bongtae Kim, Geun Seog Song, Kyung-Sang Yu, In-Jin Jang, Seung Hwan Lee
Pharmacodynamics of tegoprazan and revaprazan after single and multiple oral doses in healthy subjects. Alimentary pharmacology & therapeutics 52 (11-12) (2020)
Suhrin Lee, Seung Hwan Lee, In-Jin Jang, Kyung-Sang Yu, Su Jin Rhee
Electronic medical records-based comparison of glycemic control efficacy between sulfonylureas and dipeptidyl peptidase-4 inhibitors added on to metformin monotherapy in patients with type 2 diabetes. Translational and clinical pharmacology 28 (4) (2020)
Ji Seong Kim, Andrew HyoungJin Kim, Cholsoon Jang, In-Jin Jang, Ki-Bong Kim, Joo-Youn Cho, Ho Young Hwang
Comparison of the Plasma Metabolome Profiles Between the Internal Thoracic Artery and Ascending Aorta in Patients Undergoing Coronary Artery Bypass Graft Surgery Using Gas Chromatography Time-of-Flight Mass Spectrometry. Journal of Korean medical science 34 (13) (2019)
Eunsol Yang, Soyoung Lee, Heechan Lee, Inyoung Hwang, In-Jin Jang, Kyung-Sang Yu, Seung Hwan Lee
Pharmacokinetic comparison between fixed-dose combination of fimasartan/amlodipine 60/10 mg and the corresponding loose combination through partial replicated crossover study in healthy subjects. Translational and clinical pharmacology 27 (4) (2019)
Eunwoo Kim, Kyoung Ryun Park, In-Jin Jang, Kyung-Sang Yu, SeungHwan Lee
A Fixed-Dose Combination Of Gemigliptin And Rosuvastatin Exhibits Similar Pharmacokinetics, Pharmacodynamics, And Safety Compared To That Of A Loose Combination In Healthy Subjects. Drug design, development and therapy 13 (2019)
Andrew HyoungJin Kim, Sumin Yoon, Yujin Lee, Jieon Lee, Eunjin Bae, Hajeong Lee, Dong-Ki Kim, Seung Hwan Lee, Kyung-Sang Yu, In-Jin Jang, Joo-Youn Cho
Assessment of Hepatic Cytochrome P450 3A Activity Using Metabolic Markers in Patients with Renal Impairment. Journal of Korean medical science 33 (53) (2018)
Sunny Park, Yang Jin Hyun, Yu Ran Kim, Ju Hyun Lee, Sunae Ryu, Jeong Mi Kim, Woo Yong Oh, Han Sung Na, Jong-Gu Lee, Doo Won Seo, In Yeong Hwang, Zewon Park, In-Jin Jang, Jaeseong Oh, Seung Eun Choi
Effects of CYP2C19 Genetic Polymorphisms on PK/PD Responses of Omeprazole in Korean Healthy Volunteers. Journal of Korean medical science 32 (5) (2017)